# Left atrial stiffness as a novel echocardiographic parameter of atrial dysfunction in cats with hypertrophic cardiomyopathy: A two-dimensional speckle-tracking study

**Authors:** Patara Tohthong, Jidapa Tosuwan, Sirilak Disatian Surachetpong

PMC · DOI: 10.14202/vetworld.2025.4046-4055 · Veterinary World · 2025-12-23

## TL;DR

This study introduces left atrial stiffness (LASt) as a new echocardiographic measure to detect atrial dysfunction in cats with hypertrophic cardiomyopathy.

## Contribution

The novel contribution is the first application of LA stiffness (LASt) in feline patients as a load-adjusted marker of atrial dysfunction.

## Key findings

- Cats with HCM had significantly higher LASt values compared to normal cats.
- LASt showed strong correlations with traditional echocardiographic markers of diastolic dysfunction.
- LASt may detect atrial remodeling earlier than strain measurements alone.

## Abstract

Hypertrophic cardiomyopathy (HCM) is the most common form of cardiomyopathy in cats and is often linked with diastolic dysfunction and progressive remodeling of the left atrium (LA). While LA strain analysis has been utilized to measure atrial function, LA stiffness (LASt), a load-adjusted marker that combines diastolic filling pressures and atrial deformation (E:E’/εS), has not yet been studied in feline patients. This study aimed to compare LASt between normal cats and those with HCM and to assess its correlation with traditional echocardiographic parameters of LA and left ventricular (LV) function.

This retrospective cross-sectional study included client-owned cats evaluated at a university teaching hospital between August 2021 and August 2022. Cats were classified as normal or HCM based on LV wall thickness (≤5 mm vs. ≥6 mm). Standard echocardiographic parameters, doppler indices, tissue Doppler imaging (TDI) values, and two-dimensional speckle-tracking echocardiography (STE)–derived LA strain variables (reservoir, conduit, and active strain) were measured. LASt was calculated as E:E’/εS. Group comparisons were performed using t-tests or Mann–Whitney U tests, and correlations were assessed using Pearson’s coefficient.

Thirty-seven cats met the inclusion criteria (12 with HCM and 25 normal). Cats with HCM showed significantly higher LASt values compared to normal cats (median 2.26 vs. 0.30; p < 0.001), representing approximately a sevenfold increase. Reservoir strain (εS), conduit strain (εE), and active strain (εA) were all significantly lower in the HCM group (p < 0.001). LASt showed strong positive correlations with LA diameter and LA:Ao ratio (r ≥ 0.85; p < 0.001), and moderate-to-strong correlations with Doppler and TDI markers of diastolic dysfunction, including E:A ratio, MV A velocity, MV E’, and MV S’.

LASt, measured by STE, provides a sensitive, load-inclusive index of LA mechanical dysfunction in cats with HCM and may detect atrial remodeling earlier than strain alone. Its strong association with established markers of diastolic impairment supports its potential clinical utility for identifying subclinical atrial dysfunction. Larger longitudinal studies are warranted to validate LASt as a prognostic biomarker and to define clinically relevant thresholds for disease staging and monitoring.

## Linked entities

- **Diseases:** hypertrophic cardiomyopathy (MONDO:0005045)

## Full-text entities

- **Diseases:** Diastolic dysfunction (MESH:D018487), CHF (MESH:D006333), arrhythmias (MESH:D001145), LA (MESH:D003310), ATE (MESH:D013923), atrial enlargement (MESH:D006332), cardiomyopathies (MESH:D009202), HCM (MESH:D002312), sudden cardiac death (MESH:D016757), cardiac disease (MESH:D006331), hyperthyroidism (MESH:D006980), systole (MESH:D000092244), pulmonary venous hypertension (MESH:D006976), diastolic heart diseases (MESH:D054144), pulmonary congestion (MESH:D001261), fibrosis (MESH:D005355), hypertension (MESH:D006973), left ventricular (LV) hypertrophy (MESH:D017379), myxomatous mitral valve disease (MESH:C564326), pain (MESH:D010146), myocardial alterations (MESH:D004408), atrial (MESH:D064752), atrial stiffness (MESH:C566112), death (MESH:D003643), LV outflow tract obstruction (MESH:D000092242), congestion (MESH:D002311), cardiovascular disease (MESH:D002318), pulmonary edema (MESH:D011654), congenital heart defects (MESH:D006330), diastolic function (MESH:D006337), SDS (MESH:D000081003), atrial dysfunction (MESH:C538261)
- **Chemicals:** enoxaparin (MESH:D017984), LASt (-), T4 (MESH:D013974), clopidogrel (MESH:D000077144), pimobendan (MESH:C041648), furosemide (MESH:D005665)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Felis catus (cat, species) [taxon 9685], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913819/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913819/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913819/full.md

---
Source: https://tomesphere.com/paper/PMC12913819